Our previous study showed that Cyp4a14 is activated in mice suffering from MCD-induced liver fibrosis, and Cyp4a14–/– mice could attenuate the MCD-induced liver fibrosis, accompanied by reduced hepatic FAT/CD36 expression (Zhang et al., 2017). Here, CD36 is linked to Hepatic fibrosis.